시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 위장약 시장(-2029년)
Global Gastrointestinal Drugs Market Insights, Forecast to 2029
상품코드 : 1398343
리서치사 : QYResearch
발행일 : 2023년 12월
페이지 정보 : 영문
 라이선스 & 가격 (부가세 별도)
US $ 4,900 ￦ 7,037,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,350 ￦ 10,556,000
PDF (Multi User License) help
PDF, Excel 보고서를 동일 기업내 10명까지 이용하실 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF, Excel, Word 이용 범위와 동일합니다.
US $ 9,800 ￦ 14,074,000
PDF (Enterprise User License) help
PDF, Excel, Word 보고서를 동일 기업내 모든 구성원이 이용하실 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF, Excel, Word 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계 위장약 시장 규모는 2023년 409억 2,260만 달러에서 예측 기간 동안 4.67%의 CAGR을 기록하며 2029년에는 538억 2,000만 달러 규모로 성장할 것으로 예상됩니다.

북미 시장은 2023년 125억 7,500만 달러에서 4.35%의 CAGR로 2029년에는 162억 3,800만 달러에 달할 것으로 예상됩니다. 중국 시장은 2023년 59억 8,800만 달러에서 6.36%의 CAGR로 2029년 86억 7,000만 달러에 달할 것으로 예상됩니다. 또한, 유럽 시장은 2023년 87억 1,200만 달러에서 4.61%의 CAGR로 2029년에는 114억 2,000만 달러에 달할 것으로 예상됩니다.

세계 위장약 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 시장 규모 추이 및 예측, 유형별·용도별 분석, 지역별·주요 국가별 상세 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 내용

제2장 주요 요약

제3장 경쟁 상황 : 제조업체별

제4장 시장 규모 : 유형별

제5장 시장 규모 : 용도별

제6장 북미

제7장 유럽

제8장 중국

제9장 아시아(중국 제외)

제10장 중동, 아프리카 및 라틴아메리카

제11장 기업 개요

제12장 산업 체인과 판매 채널 분석

제13장 위장약 : 시장 역학

제14장 세계의 위장약 시장 : 주요 조사 결과

제15장 부록

ksm
영문 목차

영문목차

The global market for Gastrointestinal Drugs estimated at US$ 40922.6 million in the year 2023, is projected to reach a revised size of US$ 53820 million by 2029, growing at a CAGR of 4.67% during the forecast period 2023-2029.

The North America market for Gastrointestinal Drugs is estimated to increase from $ 12575 million in 2023 to reach $ 16238 million by 2029, at a CAGR of 4.35% during the forecast period of 2023 through 2029.

The China market for Gastrointestinal Drugs is estimated to increase from $ 5988 million in 2023 to reach $ 8670 million by 2029, at a CAGR of 6.36% during the forecast period of 2023 through 2029.

The Europe market for Gastrointestinal Drugs is estimated to increase from $ 8712 million in 2023 to reach $ 11420 million by 2029, at a CAGR of 4.61 % during the forecast period of 2023 through 2029.

The global key manufacturers of Gastrointestinal Drugs include: Takeda, Bausch Health, Abbvie, AstraZeneca, Teva, Bayer, Pfizer, Sun Pharma, etc. In 2022, the global top five players had a share approximately 40.67% in terms of revenue.

Report Includes:

This report presents an overview of global market for Gastrointestinal Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Gastrointestinal Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Gastrointestinal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastrointestinal Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Gastrointestinal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Gastrointestinal Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AstraZeneca, Sanofi, Bayer, Pfizer, GSK, Teva, Zeria, Perrigo, and Boehringer Ingelheim, etc.

By Company

Segment by Type

Segment by Application

Segment by Region

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Gastrointestinal Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

TABLE OF CONTENTS

1 STUDY COVERAGE

2 EXECUTIVE SUMMARY

3 COMPETITION BY MANUFACTURERS

4 MARKET SIZE BY TYPE

5 MARKET SIZE BY APPLICATION

6 NORTH AMERICA

7 EUROPE

8 CHINA

9 ASIA (EXCLUDING CHINA)

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

11 CORPORATE PROFILE

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

13 GASTROINTESTINAL DRUGS MARKET DYNAMICS

14 KEY FINDINGS IN THE GLOBAL GASTROINTESTINAL DRUGS STUDY

15 APPENDIX

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기